Gilead Snaps Up PE-Backed Biotech In $567M Deal
Biopharmaceutical firm Gilead Sciences Inc. said Thursday it will acquire private equity-backed biotechnology company Cell Design Labs Inc. for $567 million in a deal that will see Gilead build up its...To view the full article, register now.
Already a subscriber? Click here to view full article